# TRACE4BUS for BI-RADS Classification

> **NCT06920108** · — · NOT_YET_RECRUITING · sponsor: **DeepTrace Technologies S.r.l.** · enrollment: 590 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06920108
- **Lead sponsor:** DeepTrace Technologies S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2026-01
- **Final completion:** 2026-10
- **Target enrollment:** 590 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920108, "TRACE4BUS for BI-RADS Classification". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06920108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*